Transcatheter aortic valve implantation (TAVI) is a new treatment option for patients with severe aortic stenosis who are not candidates for open valve replacement surgery. Hospitals considering implementing a TAVI service should examine the evidence behind the procedure; recognize the issues surrounding cost, staffing, and infrastructure; and understand why the market for TAVI could extend to tens of thousands of potential candidates a year. Learn more about the web conference by clicking here.